Primary, latent and reactivating CMV infections are controlled immunologically by a number of molecular and cellular effector systems, including CD4+ and CD8+ T cells, NK cells, type I and II IFNs [38]. This evidence concerns the gene CD8A and cytomegalovirus infection.